Feature

Building Biology, Not Just Pathology

AI-driven digital pathology is accelerating drug discovery, reshaping clinical trials, and redefining the pathologist’s role in pharma

Share

AI and digital pathology are revolutionizing drug discovery and diagnostics by accelerating development processes, improving patient selection, and enhancing data quality. Monika Lamba Saini, Global Translational Pathology Leader at ADC Therapeutics, highlights these advancements. AI enables faster compound screening and lead optimization by analyzing multimodal data to identify novel biomarkers. Pathologists play a crucial role in the success of AI models by ensuring clinical relevance and interpretability, while pharmaceutical companies embrace AI for more efficient, personalized drug development strategies.

Original Source(s)

Building Biology, Not Just Pathology

  • by Jessica Allerton

  • March 11, 2026

Related Content

What Patients Really Want to Know About Precision Medicine

A molecular pathologist and a patient advocate discuss bridging the knowledge gap

Can Gene Scores Help Detect Sepsis?

Multicenter study assesses diagnostic accuracy of rapid transcriptomic testing

Pathology Captures 2026

Our annual celebration of #pathart featuring our favorite artists: The Pathologist readers!